MENU
Friday, February 25th, 2:00PM EDT

Clinical and Institutional Practice Update: Optimization of Anti-Xa Lab Test Utilization Across Care Centers

Sponsored by: Diagnostica Stago, Inc.
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract
Clinical and Institutional Practice Update: Optimization of Anti-Xa Lab Test Utilization Across Care Centers
 

Perhaps more than any other area of clinical medicine, anticoagulation management laboratory data are evaluated hourly by healthcare systems in the inpatient setting and daily in the outpatient setting to provide efficacy, safety, and markers of clinical success for drugs and disease states relating to embolic disease. These laboratory data provide answers that in their absence, or a failure of understanding, can result in patient harm or death. Accordingly, laboratory staff, pharmacists, hematologists, and pathologists supervising these efforts need concise, evidence-based, expert-endorsed information upon which to predicate their ability to understand and provide the same. This continuing education activity will discuss these issues, allowing participants to provide clinical laboratory data with the highest integrity and service to their patients.

 
Learning Objectives
  • Describe differences between unfractionated heparin (UFH), low-molecular-weight-heparin (LMWH) and direct-oral anticoagulants (DOACs) and impact on laboratory monitoring
  • Identify advantages and disadvantages of surrogate markers to monitor and measure efficacy of UFH LMWH and DOACs, focusing on reference ranges and limitations of the traditional surrogate markers and benefit of anti-Xa monitoring
  • Present management strategies for appropriate use of anti-Xa heparin level determinations
  • Highlight case studies featuring situations for which direct oral anticoagulant measurement assisted with patient management
 
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.  CE credits are available for this webinar up to 2 years from the date of the live broadcast

Show Resources
You May Also Like
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
Loading Comments...
Show Resources